Baxter International (BAX) Expected to Announce Quarterly Earnings on Thursday

Baxter International (NYSE:BAX) is projected to post its Q3 2026 results before the market opens on Thursday, October 29th. Analysts expect Baxter International to announce earnings of $0.5180 per share and revenue of $2.91 billion for the quarter. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. Parties are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, October 29, 2026 at 8:30 AM ET.

Baxter International (NYSE:BAX) last released its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 EPS for the quarter, topping the consensus estimate of $0.37 by $0.19. The business had revenue of $2.96 billion during the quarter, compared to analysts’ expectations of $2.80 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%. The company’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.59 earnings per share. On average, analysts expect Baxter International to post $2.04 EPS for the current fiscal year and $2.00 EPS for the next fiscal year.

Baxter International Stock Performance

Shares of BAX opened at $25.30 on Tuesday. Baxter International has a 1 year low of $15.73 and a 1 year high of $30.00. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.32 and a current ratio of 1.95. The company’s fifty day moving average is $24.77 and its two-hundred day moving average is $21.27. The stock has a market capitalization of $13.08 billion, a P/E ratio of -12.22, a P/E/G ratio of 3.83 and a beta of 0.65.

Baxter International Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Friday, August 28th were given a dividend of $0.01 per share. The ex-dividend date was Friday, August 28th. This represents a $0.04 annualized dividend and a yield of 0.2%. Baxter International’s payout ratio is presently -1.93%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on BAX shares. UBS Group upped their price objective on Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a report on Tuesday, July 28th. Barclays assumed coverage on shares of Baxter International in a report on Wednesday, October 7th. They set an “underweight” rating and a $20.00 price objective on the stock. Weiss Ratings lowered shares of Baxter International from a “sell (d)” rating to a “sell (d-)” rating in a research report on Thursday, October 8th. The Goldman Sachs Group increased their target price on shares of Baxter International from $19.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday, July 15th. Finally, Wall Street Zen downgraded shares of Baxter International from a “buy” rating to a “hold” rating in a research report on Saturday, October 10th. One equities research analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, Baxter International presently has an average rating of “Reduce” and a consensus price target of $21.73.

Baxter International Company Profile

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.